Publication | Open Access

New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus

Medicinal ChemistryTopoisomerase Iv InhibitorsMethicillin-resistant Staphylococcus AureusAntibioticsHealth SciencesMedicineAntimicrobial SusceptibilityDna GyraseAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance